Kyphoscoliosis Surgery: Blood Conservation and Analgesia
NCT ID: NCT03319563
Last Updated: 2020-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2017-04-11
2017-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
local anesthetic-epinephrine group
after general anesthesia, the Infiltration cocktail was done by the surgeon at three levels:
1. Subcutaneous: before incision at a volume 20 ml/10 cm/side.
2. Muscular Paravertebral: before opening the thoracolumbar fascia, using the same previous volume.
3. Neural paravertebral: after exposure of the transverse processes. A volume of 5 ml/per each process of the same cocktail, 1 cm deep to the surface of the corresponding process before pedicular screws fixation after negative blood aspiration.
Local anesthetic-epinephrine
* Bupivacaine 0.5% (Astra Zeneca) 2 mg/Kg.
* Lidocaine 5 mg/Kg.
* Epinephrine 5 mcg/ml of the total volume.
* Add normal saline to a total volume of 100 ml/10 cm of the wound length.
saline group
after general anesthesia, the same infiltration volume and technique using normal saline.
Saline
normal saline 100 ml/10 cm of the wound length
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Local anesthetic-epinephrine
* Bupivacaine 0.5% (Astra Zeneca) 2 mg/Kg.
* Lidocaine 5 mg/Kg.
* Epinephrine 5 mcg/ml of the total volume.
* Add normal saline to a total volume of 100 ml/10 cm of the wound length.
Saline
normal saline 100 ml/10 cm of the wound length
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Age 8-18 years.
3. American Society of Anesthesiologists I-II status.
Exclusion Criteria
2. Infection at surgical site.
3. Hypersensitivity to amide local anesthetics.
4. Coagulopathy.
5. Blood diseases as sickle cell anemia, hemophilia, idiopathic thrombocytopenic purpura.
6. Sever cardiac, respiratory, renal or hepatic impairment.
7. Presence of communication barrier.
8 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alaa Mazy Mazy
Associate professor of anesthesia and surgical intensive care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University Hospital and Delta Hospital
Al Mansurah, Dakahlya, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PACTR201703002123104
Identifier Type: REGISTRY
Identifier Source: secondary_id
R/17.02.85
Identifier Type: -
Identifier Source: org_study_id